Clearmind MedicineCMND

13F holders, Q2 2025 (June 30)
9holders +2
3new positions
1sold out
1famous investor
$9.35avg. 13F price*

At the end of Q2 2025, 9 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, up 2 from Q1 2025. 3 opened new positions and 1 sold out. The largest holders were Gotham Asset Management ($5.3M), AdvisorShares Investments LLC ($182K) and Cornerstone Wealth Group, LLC ($18K). One famous investor held it Joel Greenblatt (0.0% of Gotham Asset Management's portfolio).

Company
Clearmind Medicine Inc.
CUSIP
185053402
Latest filing quarter
Q3 2025

History

Number of 13F holders

0246810 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 8Q3 2024Q4 2024: 9Q4 2024Q1 2025: 7Q1 2025Q2 2025: 9Q2 2025Q3 2025: 7Q3 2025

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions3$14K
Exits1$14K

All 13F filers, Q1 2025 → Q2 2025: 16,548 shares bought and 28,903 shares sold, net −12,355 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 9 holders

Gotham Asset Management 0.03% Add +0.3% 344,521 $5.3M
AdvisorShares Investments LLC 0.03% Reduce -6.8% 205,933 $182K
Cornerstone Wealth Group, LLC 0.00% No change 20,000 $18K
XTX Topco Ltd 0.00% New 11,523 $10K
JPMorgan Chase & Co. 0.00% New 3,536 $3K
Morgan Stanley 0.00% No change 2,564 $2K
Royal Bank of Canada 0.00% No change 569 $1K
Osaic Holdings, Inc. 0.00% New 395 $355
National Bank of Canada 0.00% No change 379 $334

"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.